Description of the Use of fidAxomicin in Hospitalized Patients With Documented Clostridium diFficile iNfection and of the managEment of These Patients

• Status: Completed
• Trial end date: 2017-08-17
• Target enrollment: 0
• Participant gender: All

Summary

The study aims to describe the characteristics and the methods of management and follow-up of patients treated with fidaxomicin for Clostridium difficile infection (CDI).

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Astellas Pharma S.A.S.
• Treatments: Fidaxomicin

Criteria

Inclusion Criteria:

• Hospitalized patient

• Patient diagnosed with CDI

Exclusion Criteria:

• Patient already included in this study

• Patient is taking part in a clinical trial in the field of CDI